By Canadian Press

Moderna establishing Canadian division amid COVID-19 vaccine rollout

Dec 21, 2020 | 12:37 PM

OTTAWA — U.S. biotech firm Moderna is establishing a Canadian office as it ramps up plans to rolls out its COVID-19 vaccine here as soon as Health Canada approves it.

Patricia Gauthier, the new general manager for the Canadian office, says the company had been eyeing expanding outside the United States before COVID-19 but the pandemic accelerated those plans.

She was hired three weeks ago and remains the only Canadian employee for now, with an initial focus on helping the Canadian government get the Moderna vaccine approved, shipped and injected.

She says that includes efforts to communicate to Canadians the safety and effectiveness of the vaccine, which uses a novel genetic technology to train the immune system to fight off the virus that causes COVID-19.

Health Canada is in the final stage of its review of Moderna’s vaccine, looking to ensure the manufacturing facility and process meet expected standards.

Court proceedings

'The impact of this trauma will echo for generations': court case surrounding La Ronge woman's death reaches conclusion

22h ago

Going Global

P.A.'s Zablocki named to Team Canada for U18 Women's World Championships

22h ago

Election 2024

Birch Hills staff won't share election decision

23h ago

Moderna is expected to be the second COVID-19 vaccine approved for use in Canada, with enough doses available in 2021 to vaccinate two-thirds of Canada’s adult population.

This report by The Canadian Press was first published Dec. 21, 2020.

Mia Rabson, The Canadian Press